PURPOSE:
We have previously shown that plasma from open, but not laparoscopic-assisted, surgery patients has increased mitogenic activity for colon cancer cells. Decreased insulin-like growth factor binding protein 3 levels, most likely the result of an open surgery-induced proteolytic activity, may account for this finding. Plasma proteases are activated by interleukin-6. This study was designed to investigate plasma insulin-like growth factor binding protein 3 and interleukin-6 levels after major open or laparoscopic-assisted surgery.
METHODS:
EDTA plasma was obtained from 24 patients undergoing resection for colonic adenocarcinoma. Insulin-like growth factor binding protein 3 was detected by Western blot analysis and enzyme-linked immunosorbent assay. Interleukin-6 levels were determined by enzyme-linked immunosorbent assay. The effect of insulin-like growth factor binding protein 3 on tumor growth was tested using HCT116 cells.
RESULTS:
In patients undergoing open surgery, enzyme-linked immunosorbent assay revealed a significant decrease in total insulin-like growth factor binding protein 3 levels on postoperative Day 1 (915.6 ± 378.5 ng/ml) compared with preoperative levels (1,267.5 ± 407.9 ng/ml; P < 0.001). Western blots revealed a decrease in the levels of intact insulin-like growth factor binding protein 3. In patients undergoing laparoscopic-assisted surgery, levels of total and intact insulin-like growth factor binding protein 3 before surgery (1,088.9 ± 232.5 ng/ml) and on postoperative Day 1 (1,202.3 ± 285.6 ng/ml) were comparable with no significant changes in Western blot analysis. Interleukin-6 levels were undetectable preoperatively. On postoperative Day 1, interleukin-6 concentration was higher in open surgery group (434.8 ± 506.6 pg/ml) compared with laparoscopic-assisted surgery group (100.9 ± 60.2 pg/ml; P < 0.0001), and correlated significantly with a decrease in plasma insulin-like growth factor binding protein 3 after open surgery (r = 0.81; P < 0.0001).
CONCLUSIONS:
A significant decrease in both total and free insulin-like growth factor binding protein 3 occurs after open but not laparoscopic colectomy. There is an associated increase in the levels of interleukin-6. It remains to be proven that the interleukin-6 elevations are responsible for the low insulin-like growth factor binding protein 3 level seen after open surgery.
Similar content being viewed by others
References
To the article
M Braga A Vignali L Gianotti et al. (2002) ArticleTitleLaparoscopic versus open colorectal surgery: a randomized trial on short-term outcome Ann Surg 236 759–66
I Kirman V Cekic N Poltaratskaia et al. (2002) ArticleTitlePlasma from patients undergoing major open surgery stimulates in vitro tumor growth: lower insulin-like growth factor binding protein 3 levels may, in part, account for this change Surgery 132 186–92
ML Cubbage A Suwanichkul DR Powell (1990) ArticleTitleInsulin-like growth factor binding protein-3. Organization of the human chromosomal gene and demonstration of promoter activity J Biol Chem 265 12642–9
MS Lewitt H Saunders JL Phuyal RC Baxter (1994) ArticleTitleComplex formation by human insulin-like growth factor-binding protein-3 and human acid-labile subunit in growth hormone-deficient rats Endocrinology 134 2404–9
B Valentinis A Bhala T DeAngelis R Baserga P Cohen (1995) ArticleTitleThe human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene Mol Endocrinol 9 361–7
J Hong G Zhang F Dong MM Rechler (2002) ArticleTitleInsulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells J Biol Chem 277 10489–97
BA Booth M Boes RS Bar (1996) ArticleTitleIGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragments Am J Physiol 271 E465–70
SK Durham A Suwanichkul JD Hayes AC Herington DR Powell PG Campbell (1999) ArticleTitleThe heparin binding domain of insulin-like growth factor binding protein (IGFBP)-3 increases susceptibility of IGFBP-3 to proteolysis Horm Metab Res 31 216–25
P Cohen DM Peehl HC Graves RG Rosenfeld (1994) ArticleTitleBiological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease J Endocrinol 142 407–15
M Claussen B Kubler M Wendland et al. (1997) ArticleTitleProteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D Endocrinology 138 3797–803
A Lemmey P Maddison A Breslin et al. (2001) ArticleTitleAssociation between insulin-like growth factor status and physical activity levels in rheumatoid arthritis J Rheumatol 28 29–34
F Benedetti ParticleDe C Meazza M Oliveri et al. (2001) ArticleTitleEffect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis Endocrinology 142 4818–26
A Grimberg B Liu P Bannerman WS El-Deiry P Cohen (2002) ArticleTitleIGFBP-3 mediates p53-induced apoptosis during serum starvation Int J Oncol 21 327–35
R Rajah B Valentinis P Cohen (1997) ArticleTitleInsulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism J Biol Chem 272 12181–8
KL Leung PB Lai RL Ho et al. (2000) ArticleTitleSystemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma: a prospective randomized trial Ann Surg 231 506–11
F Groof Particlede KF Joosten JA Janssen et al. (2002) ArticleTitleAcute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors J Clin Endocrinol Metab 87 3118–24
A Raynaud-Simon L Perin S Meaume et al. (2002) ArticleTitleIGF-I, IGF-I-binding proteins and GH-binding protein in malnourished elderly patients with inflammation receiving refeeding therapy Eur J Endocrinol 146 657–65
AL Crown K Cottle SL Lightman et al. (2002) ArticleTitleWhat is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated? Clin Endocrinol 56 723–33
F Benedetti ParticleDe C Meazza A Martini (2002) ArticleTitleRole of interleukin-6 in growth failure: an animal model Review. Horm Res 58 24–7
T Tsujinaka J Fujita C Ebisui et al. (1996) ArticleTitleInterleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice J Clin Invest 97 244–9
A Gerber A Wille T Welte S Ansorge F Buhling (2001) ArticleTitleInterleukin-6 and transforming growth factor-beta 1 control expression of cathepsins B and L in human lung epithelial cells J Interferon Cytokine Res 21 11–9
JA Solis-Herruzo RA Rippe LW Schrum et al. (1999) ArticleTitleInterleukin-6 increases rat metalloproteinase-13 gene expression through stimulation of activator protein 1 transcription factor in cultured fibroblasts J Biol Chem 274 30919–26
M Yamamoto S Ikeda H Kondo S Inoue (2002) ArticleTitleDesign and synthesis of dual inhibitors for matrix metalloproteinase and cathepsin Bioorg Med Chem Lett 12 375–8
RC Baxter (2001) ArticleTitleSignalling pathways involved in antiproliferative effects of IGFBP-3: a review Mol Pathol 54 145–8
K Yamaguchi Y Takagi S Aoki M Futamura S Saji (2000) ArticleTitleSignificant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection Ann Surg 232 58–65
S Ito H Nakanishi T Hirai et al. (2002) ArticleTitleQuantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler Cancer Lett 183 195–203
Fanayan S, Firth SM, Butt AJ, Baxter RC. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta) and the type II TGF-beta receptor. J Biol Chem 200015;275:39146–51
J Hong G Zhang F Dong MM Rechler (2002) ArticleTitleInsulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells J Biol Chem 277 10489–97
To the Authors Reply
F Benedetti ParticleDe C Meazza M Oliveri et al. (2001) ArticleTitleEffect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis Endocrinology 142 4818–26
I Kirman V Cekic N Poltaratskaia et al. (2002) ArticleTitlePlasma from patients undergoing major open surgery stimulates in vitro tumor growth: lower insulin-like growth factor binding protein 3 levels may, in part, account for this change Surgery 132 186–92
Fanayan S, Firth SM, Butt AJ, Baxter RC. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta) and the type II TGF-beta receptor. J Biol Chem 200015;275:39146–51
J Hong G Zhang F Dong MM Rechler (2002) ArticleTitleInsulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells J Biol Chem 277 10489–97
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by grants from Minimal Access Surgery Center at the New York-Presbyterian Hospital.
About this article
Cite this article
Kirman, I., Poltaratskaia, N., Cekic, V. et al. Depletion of Circulating Insulin-Like Growth Factor Binding Protein 3 After Open Surgery is Associated With High Interleukin-6 Levels. Dis Colon Rectum 47, 911–918 (2004). https://doi.org/10.1007/s10350-004-0512-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10350-004-0512-4